Literature DB >> 11040480

Which ocular and neurologic conditions cause disparate results in visual acuity scores recorded with visually evoked potential and teller acuity cards?

C A Westall1, J R Ainsworth, J R Buncic.   

Abstract

PURPOSE: We investigated whether disparity between visually evoked potential (VEP) acuity scores and Teller Acuity Card (TAC) scores varied according to presence of ocular or neurologic conditions.
METHODS: Charts from 175 children (mean age, 34.8 months; range, 3 to 158 months) referred for visual acuity testing were examined. All children had been tested with pattern-alternation VEP and TAC and had undergone a complete eye examination. VEP and TAC acuity scores were relative to age-expected acuity scores for each acuity test. The absence and degree of macular abnormality, retinal abnormality, optic nerve hypoplasia, optic nerve atrophy, cortical visual impairment, developmental delay, cerebral palsy, seizures, and nystagmus were noted. Analysis of variance models were used to determine whether differences between VEP and TAC scores varied according to the presence of specific deficits. Logistic regression analysis determined whether degree of specific deficits was associated with a greater chance of inconsistency between VEP and TAC scores (>0.3 log unit difference).
RESULTS: Inconsistent scores were found in 48% of children. Developmental delay was associated with relatively poorer TAC than VEP score, and the chance of inconsistency increased with severity of developmental delay.
CONCLUSIONS: Diagnosis-dependent variability exists between TAC and VEP scores. Therefore knowledge of the clinical picture is necessary in interpretation of VEP and TAC scores. It is not clear which test is more useful when a disparity exists, either from this or previous studies. When visual acuity is assessed longitudinally in a given child, then consistency in method for acuity assessment is important.

Entities:  

Mesh:

Year:  2000        PMID: 11040480     DOI: 10.1067/mpa.2000.107898

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  7 in total

1.  Development of a quantitative method to measure vision in children with chronic cortical visual impairment.

Authors:  W V Good
Journal:  Trans Am Ophthalmol Soc       Date:  2001

2.  The Hospital for Sick Children, Toronto, Longitudinal ERG study of children on vigabatrin.

Authors:  Carol A Westall; William J Logan; Kim Smith; J Raymond Buncic; Carole M Panton; Mohamed Abdolell
Journal:  Doc Ophthalmol       Date:  2002-03       Impact factor: 2.379

3.  Similarities and differences between behavioral and electrophysiological visual acuity thresholds in healthy infants during the second half of the first year of life.

Authors:  Claudia Polevoy; Gina Muckle; Jean R Séguin; Emmanuel Ouellet; Dave Saint-Amour
Journal:  Doc Ophthalmol       Date:  2017-02-20       Impact factor: 2.379

Review 4.  VEP estimation of visual acuity: a systematic review.

Authors:  Ruth Hamilton; Michael Bach; Sven P Heinrich; Michael B Hoffmann; J Vernon Odom; Daphne L McCulloch; Dorothy A Thompson
Journal:  Doc Ophthalmol       Date:  2020-06-02       Impact factor: 2.379

5.  Paradoxical robust visual evoked potentials in young patients with cortical blindness.

Authors:  Tamara Wygnanski-Jaffe; Carole M Panton; J Raymond Buncic; Carol A Westall
Journal:  Doc Ophthalmol       Date:  2009-06-23       Impact factor: 2.379

6.  Visual evoked potential importance in the complex mechanism of amblyopia.

Authors:  Regina Halfeld Furtado de Mendonça; Stefania Abbruzzese; Bruna Bagolini; Italo Nofroni; Eliana Lucia Ferreira; James Vernon Odom
Journal:  Int Ophthalmol       Date:  2013-02-16       Impact factor: 2.031

Review 7.  Assessment of Human Visual Acuity Using Visual Evoked Potential: A Review.

Authors:  Xiaowei Zheng; Guanghua Xu; Kai Zhang; Renghao Liang; Wenqiang Yan; Peiyuan Tian; Yaguang Jia; Sicong Zhang; Chenghang Du
Journal:  Sensors (Basel)       Date:  2020-09-28       Impact factor: 3.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.